Medication Adherence in Palliative Care Patients.
adherence to therapy
cancer and oncology
medication adherence strategies
outpatient clinic
palliative care services
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
accepted:
25
05
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Background In palliative care, therapeutic benefit and desired health outcome might be affected by non-adherence to medications, especially among patients with advanced illnesses, such as cancer. The consequences of non-adherence to medications could include poor health outcomes, recurrent admissions, medication waste, as well as increased morbidity and mortality. The aim of this study was to measure the level of medication adherence in palliative care patients visiting the outpatient clinic at King Fahad Medical City. Methods Inclusion criteria comprised all palliative care patients visiting the outpatient clinic in King Fahad Medical City. Medication adherence was assessed among the participants using the Morisky Medication Adherence Scale (MMAS). Data analysis was conducted using SPSS and GraphPad Prism. Results A total of 84 responses were recorded. Among the respondents, 58.3% were female. The most common underlying diseases among participants were breast cancer. Of the 84 participants, 59 (70.2%) patients reported good adherence, while 25 (29.7%) reported poor adherence. Conclusion Non-adherence to medications among palliative care patients is a significant public health problem. Results indicated that the overall level of medication adherence in palliative care patients was moderate to good. Further studies are required to design new techniques for increasing medication adherence in palliative care patients.
Identifiants
pubmed: 35755505
doi: 10.7759/cureus.25322
pmc: PMC9230914
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e25322Informations de copyright
Copyright © 2022, AlShehri et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Med Care. 1998 Aug;36(8):1138-61
pubmed: 9708588
Oman Med J. 2011 May;26(3):155-9
pubmed: 22043406
J Pain Symptom Manage. 2013 Jan;45(1):43-55
pubmed: 22841408
BMC Fam Pract. 2019 Sep 14;20(1):132
pubmed: 31521114
Milbank Q. 2011 Sep;89(3):343-80
pubmed: 21933272
Geriatr Gerontol Int. 2016 Oct;16(10):1093-1101
pubmed: 26482548
Am J Health Syst Pharm. 2003 Apr 1;60(7):657-65
pubmed: 12701547
Biomed Res Int. 2015;2015:217047
pubmed: 26539470
Hosp Pharm. 2017 Feb;52(2):124-131
pubmed: 28321139
Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1709-1726
pubmed: 29200118
Singapore Med J. 2002 Jun;43(6):273-5
pubmed: 12380721
Arch Intern Med. 2007 Mar 26;167(6):540-50
pubmed: 17389285
J Pain Symptom Manage. 2009 Jun;37(6):1006-18
pubmed: 19500723
J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):90-4
pubmed: 21247831
Palliat Med. 2001 Jul;15(4):287-95
pubmed: 12054146
Med Care. 2004 Mar;42(3):197-9
pubmed: 15076818
Med Care. 2004 Mar;42(3):200-9
pubmed: 15076819